ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 13

Shared Genetic Origins Among Anti-Proteinase 3 and Anti-Glomerular Basement Membrane Double-Positive Human Autoantibodies

Jeffrey R. Ord1, Amy G. Clark1 and Mary H. Foster2, 1Duke University Medical Center, Durham, NC, 2Medicine, Duke University Medical Center, Durham, NC

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ANCA, autoantibodies, autoimmunity and environmental factors, B cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with ANCA vasculitis and anti-glomerular basement membrane (GBM) nephritis (Goodpasture’s Disease) develop pathogenic autoantibodies (autoAb) that destroy the microvasculature in lungs and kidneys. A substantial subset of patients develops double-positive (DP) ANCA+ anti-GBM+ autoAb and a clinical overlap syndrome. A recent analysis of a large patient cohort suggests that clinical relapse is particularly likely in the surviving DP patients with anti-PR3 ANCA. Little is known about the sequence and structure of autoAb of either specificity or about the relationship between ANCA and anti-GBM autoAb in DP patients. To gain insight into the origins of human anti-PR3 DP autoAb, we took advantage of the HuHSC-NSG model in which conditioned immunodeficient NOD-scid-gamma (NSG) mice are injected with human hematopoietic stem cells (HSC) to reconstitute a human immune system in vivo.

Methods: We measured binding to purified native human PR3 in two panels of HuHSC-NSG-derived human antibodies: 1) Six clonally unrelated human anti-GBM monoclonal antibodies (mAb) previously generated from collagen-immunized HuHSC-NSG mice and selected for binding to the non-collagenous domain-1 of the alpha3 chain of collagen IV, the antigen targeted by pathogenic anti-GBM autoAb; and, 2) Serum from a cohort of HuHSC-NSG mice (n=29) 4-6 months post engraftment and 1-3 months post aspiration of vehicle (saline) or crystalline silica, the environmental exposure most compellingly linked to human autoimmunity including ANCA vasculitis. Results using ELISA are reported as mean sample OD after subtraction of mean OD on diluent-coated plates.

Results: Two human anti-GBM mAb bound to PR3 (ODs = 0.618 and 0.455; positive control ANCA+ patients’ plasma IgG diluted 1:50 mean OD = 1.376). PR3 binding did not reflect broad polyreactivity, as neither mAb bound to MPO or Hep-2 cells. Low level anti-PR3 activity (mean OD = 0.084, diluted 1:50) was detected among human antibodies in the blood of a subset of silica-exposed HuHSC-NSG subjects derived from the same HSC unit.

Conclusion: Detection of both anti-GBM and anti-PR3 specificities in individual human mAb confirms that a single immunoglobulin can bind both autoantigens and that anti-GBM and anti-PR3 autoAb can share genetic origins. Prior sequence analysis of the human mAb revealed uncommon motifs that favor autoreactivity and are typically selected against in the immune repertoire. Our findings in humanized immune system mice suggest that genetics of the HSC donor and permissive environmental exposures may facilitate their expression. Sequence analysis of single-positive anti-PR3 and patients’ pathogenic autoAb will provide further insight into their genetic relationship and immune regulation, as well as potential novel targets for therapy.


Disclosure: J. R. Ord, None; A. G. Clark, None; M. H. Foster, None.

To cite this abstract in AMA style:

Ord JR, Clark AG, Foster MH. Shared Genetic Origins Among Anti-Proteinase 3 and Anti-Glomerular Basement Membrane Double-Positive Human Autoantibodies [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/shared-genetic-origins-among-anti-proteinase-3-and-anti-glomerular-basement-membrane-double-positive-human-autoantibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/shared-genetic-origins-among-anti-proteinase-3-and-anti-glomerular-basement-membrane-double-positive-human-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology